Lead Beneficiary: VUMC (Amsterdam, Netherlands)
Objectives:
- to understand how cohesinopathy-derived mutations affect different cellular pathways underlying specific disease phenotypes
- to identify developmental pathways that are altered in cohesinopathies
- to unravel the crosstalk of cohesin and Polycomb repressive complexes in gene expression regulation in normal and cancer cells